The assessment of curcumin in comparison with placebo on the auditory neuropathy in chronic kidney disease and diabetes mellitus patients
Phase 3
Recruiting
- Conditions
- Chronic kidney disease.Chronic kidney disease (CKD)
- Registration Number
- IRCT20210620051629N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All chronic kidney and diabetic patients with definitive diagnosis of nephrologist and endocrinologist who have been ill for more than 6 months
All patients with chronic renal disease and diabetes with definitive diagnosis who have hearing impairment in the initial evaluation
All chronic renal and diabetic patients with definitive diagnosis with glomerular filtration rate less than 60
Exclusion Criteria
Use of aspirin and warfarin
Mental diseases
Usage of other complementary medicine methods
Pregnancy
lactation
Usage of other antioxidant drugs except Nephrovit pills
Having gallstones
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hearing threshold based on auditory brain stem responses (ABR). Timepoint: Before intervention, After intervention. Method of measurement: Minimum hearing threshold based on auditory brain stem responses (ABR).
- Secondary Outcome Measures
Name Time Method